Anbio Biotechnology (NASDAQ:NNNN) Trading Down 8.2% – Time to Sell?

Shares of Anbio Biotechnology (NASDAQ:NNNN) fell 8.2% on Wednesday . The stock traded as low as $12.60 and last traded at $12.5830. 7,772 shares were traded during mid-day trading, a decline of 83% from the average session volume of 44,722 shares. The stock had previously closed at $13.71.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Anbio Biotechnology Stock Performance

The stock’s 50-day simple moving average is $24.34.

Anbio Biotechnology (NASDAQ:NNNN) last posted its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 earnings per share for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.